Focused on the patient - Baylor Health Care System

More documents

Recommendations

Info

24<strong>Focused</strong> on qualityTable 2 Staging of 2006 analytical cases from the Baylor Dallas Cancer RegistryGeneral stage of analytical casesPrimary site Non-analytical Total analytical In situ Localized Regional Distant Unk/NAHead and neck 22 50 0 17 23 3 7Tongue 7 20 0 8 9 2 1Lip/oral cavity 11 20 0 8 7 0 5Pharynx 4 9 0 0 7 1 1Other 0 1 0 1 0 0 0Digestive 231 682 8 244 229 144 57Esophagus 21 22 0 8 11 1 2Stomach 18 79 0 26 23 17 13Colon 86 138 2 51 46 34 5Rectum 25 100 2 43 33 13 9Anus and anal canal 10 10 2 5 1 0 2Liver and Intrahepatic bile ducts 30 154 0 79 55 12 8Pancreas 25 115 2 9 40 51 13Other digestive organs 16 64 0 23 20 16 5Respiratory 124 323 3 74 90 139 17Larynx 7 15 1 3 7 3 1Lung and bronchus 115 301 2 70 80 134 15Other respiratory organs 2 7 0 1 3 2 1Bone and joints 5 11 0 3 6 2 0Soft tissue (including heart) 15 37 0 19 10 5 3Skin (excluding basal and squamous) 58 75 12 38 13 4 8Melanoma skin 46 72 12 36 13 3 8Other nonepithelial skin 12 3 0 2 0 1 0Breast 152 597 110 329 135 7 16Reproductive organs 205 478 23 276 98 67 14Uterine cervix 17 40 3 24 9 3 1Uterine corpus 9 112 0 73 28 7 4Ovary 26 78 0 18 10 47 3Vulva 5 36 18 12 5 0 1Other genital, female 1 5 1 1 1 1 1Prostate 139 190 0 139 39 8 4Testis 6 15 0 8 6 1 0Penis and other genital, male 2 2 1 1 0 0 0Urinary 58 211 29 119 25 30 8Urinary bladder 22 53 26 20 5 1 1Kidney and renal pelvis 36 155 1 98 20 29 7Ureter and other urinary organs 0 3 2 1 0 0 0Eyes 0 0 0 0 0 0 0Brain/central nervous system 106 171 0 55 2 0 114Endocrine 25 95 0 42 11 6 36Thyroid 10 59 0 40 10 5 4Other endocrine 15 36 0 2 1 1 32Leukemia 116 113 0 0 0 113 0Lymphoma 140 147 0 41 11 75 20Hodgkin’s 22 15 0 1 2 10 2Non-Hodgkin’s 118 132 0 40 9 65 18Multiple myeloma 72 36 0 1 0 34 1All other 64 120 0 1 5 32 82Total 1,393 3,146 185 1,259 658 661 383Analytical cases are cases in which patients were first diagnosed or initially treated at Baylor.
<strong>Focused</strong> on quality 25Patient Care Evaluation Study:Surgical Staging for Low-Risk Endometrial Cancerby Kamilia Smith, MD, and E. Colin Koon, MD, PhDEndometrial cancer is the most common gynecologic malignancy in the United States. Anestimated 39,000 cases of uterine cancer were diagnosed in 2007. In 75% of cases, thedisease is confined to the uterus. 1Dr. Kamilia SmithHistorically, endometrial cancer was staged clinically. In 1988, the International Federationof Gynecologists and Obstetricians recommended a change from clinical to surgical staging,including lymph node sampling. Today, surgical staging remains the cornerstone of treatment;however, the extent of the lymphadenectomy has not been clearly defined. In surgicalstaging series, the risk of pelvic nodal metastases in what would otherwise be surgical stageI disease is
Page 1 and 2: Baylor Charles A. SammonsCancer Cen
Page 3: FROM THE DIRECTOR 1The Baylor Sammo
Page 6 and 7: 4Focused on youThi
Page 8 and 9: 6Focused on youAt
Page 10: 8Focused on youUni
Page 14 and 15: 12Focused on speci
Page 23 and 24: Focused on quality
Page 25: Focused on quality
Page 29 and 30: Focused on quality
Page 31: Focused on quality
Page 34 and 35: 32Focused on colla
Page 37 and 38: Focused on innovat
Page 43 and 44: Baylor Sammons Cancer Center Teleph

Focused on the patient - Baylor Health Care System

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?